Imprimis Pharmaceuticals Inc. | Mutual Funds
Mutual Funds that own Imprimis Pharmaceuticals Inc.
Vanguard Total Stock Market Index Fund
483,269
2.29%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
191,701
0.91%
0
0%
07/31/2018
Jacob Micro Cap Growth Fund
71,389
0.34%
20,000
1.87%
02/28/2018
Altair Smaller Companies Fund
59,000
0.28%
0
0.05%
02/28/2018
iShares Micro Cap ETF
48,880
0.23%
0
0.01%
09/06/2018
Fidelity Spartan Extended Market Index Fund
47,994
0.23%
0
0%
07/31/2018
iShares Core S&P Total US Stock Market ETF
33,899
0.16%
0
0%
09/06/2018
Vanguard Institutional Total Stock Market Index Fund
24,030
0.11%
0
0%
07/31/2018
Fidelity Spartan Total Market Index Fund
10,757
0.05%
0
0%
07/31/2018
Fidelity Nasdaq Composite Index
10,102
0.05%
0
0%
07/31/2018
| Address |
12264 El Camino Real
San Diego California 92130
United States
|
|
Employees
|
- |
| Website |
http://www.imprimispharma.com |
| Updated |
09/14/2018 |
| Imprimis Pharmaceuticals, Inc. engages in the development, production, and dispensing of innovative proprietary compounded pharmaceuticals. The company was founded by Mark L. Baum and Robert J. |
